Cathie Wood’s ARK Invest executed a major portfolio reshuffle on November 7, 2025, continuing its recent trend of reducing exposure to Tesla Inc. At the same time, the firm redirected capital into cryptocurrency-focused and high-growth technology names.
Tesla Sale and BitMine Purchase
On November 7, ARK sold 71,638 Tesla shares worth approximately $31.94 million. Tesla has been a cornerstone of ARK’s flagship Innovation ETF since 2018, but the latest sale follows a pattern of trimming the position after shareholders approved Elon Musk’s compensation package. Meanwhile, ARK deployed about $2 million into BitMine Immersion Technologies, acquiring 48,454 shares across three ETFs:
– ARK Next Generation Internet ETF
– ARK Innovation ETF
– ARK Fintech Innovation ETF
BitMine, ticker BMNR, has pivoted into an Ethereum treasury strategy as of June 30, 2025. The company holds nearly 3.4 million ETH, purchasing over 565,000 ETH in the past month alone. Following ARK’s announcement, BitMine shares jumped 7.65% to $40.23 in after-hours trading. The stock is up 415% year-to-date, although CryptoQuant data shows roughly $2.1 billion in unrealized losses on its ETH holdings due to market declines.
Trade Desk and Bullish: Digital Advertising and Crypto Exchange
ARK’s largest single purchase of the day was 316,072 shares of Trade Desk Inc., valued at $14.51 million. This acquisition signals growing interest in the digital advertising sector.
In the crypto exchange space, ARK bought 238,000 shares of Bullish — worth roughly $12 million — ahead of its November 19 earnings report. The ARK Innovation ETF accounted for 164,214 of those shares. Bullish posted $57 million in adjusted Q2 2025 revenue (down from $67 million in Q2 2024) but swung to a $108.3 million net income from a $116.4 million loss a year earlier. Since going public at a $1.1 billion valuation, ARK has accumulated about $172 million in Bullish shares.
Biotech and Other Trades
ARK also boosted its biotechnology exposure with:
– 1,046,699 shares of Intellia Therapeutics ($12.90 million)
– Beam Therapeutics shares worth $4.28 million
– Twist Bioscience shares worth $4 million
On the sell side, the firm trimmed several positions:
– 236,749 shares of GitLab for $10.79 million
– 84,988 shares of Roku for $8.91 million
– 20,277 shares of Natera for $4.02 million
– 26,479 shares of Iridium Communications for $0.45 million
This strategic rebalance underscores ARK’s emphasis on emerging technologies, decentralized finance and targeted biotech innovations as it continues to adjust its flagship portfolios.
https://coincentral.com/cathie-woods-ark-invest-sells-32-million-tesla-stock-buys-bitmine-ethereum-treasury-shares/
